Nanobody-mediated imaging and blocking of the inhibitory receptor LAG3.

Breckpot, Karine (Administrative Promotor)
Lecocq, Quentin (Medewerker)

Acroniem	ANI173
Status	Geëindigd
Effectieve start/einddatum	1/10/16 → 30/09/17

Noninvasive Imaging of the Immune Checkpoint LAG-3 Using Nanobodies, from Development to Pre-Clinical Use
Lecocq, Q., Zeven, K., De Vlaeminck, Y., Martens, S., Massa, S., Goyvaerts, C., Raes, G., Keyaerts, M., Breckpot, K. & Devoogdt, N., 29 sep. 2019, In: Biomolecules. 9, 10, 20 blz., 548.
Onderzoeksoutput: Scientific review › peer review

Open Access
Bestand
52 Citaten (Scopus)

316 Downloads (Pure)
Theranostics in immuno-oncology using nanobody derivatives
Lecocq, Q., De Vlaeminck, Y., Hanssens, H., D'Huyvetter, M., Raes, G., Goyvaerts, C., Keyaerts, M., Devoogdt, N. & Breckpot, K., 25 okt. 2019, In: Theranostics. 9, 25, blz. 7772-7791 20 blz., 10.7150/thno.34941.
Onderzoeksoutput: Scientific review › peer review

Open Access
Bestand
126 Citaten (Scopus)

612 Downloads (Pure)